Quotient Bioresearch

CAMBRIDGE, England - - Acquired Business to Provide Quotient-Amersham Radiochemicals Branded Products and Services - Major Investment in new radiochemicals facility to be Located in Cardiff, Wales Quotient Bioresearch Limited ("Quotient"), a leading provider of drug development services, announces that it has reached an agreement to acquire Amersham Radiolabeling Services ("Amersham Radiolabeling Services"), the radiochemical custom synthesis operations of GE Healthcare.